Compare · ALB vs BCPC
ALB vs BCPC
Side-by-side comparison of Albemarle Corporation (ALB) and Balchem Corporation (BCPC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and BCPC operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $11.59B, about 2.1x BCPC ($5.44B).
- Over the past year, ALB is down 0.7% and BCPC is up 13.0% - BCPC leads by 13.8 points.
- ALB has been more active in the news (5 items in the past 4 weeks vs 1 for BCPC).
- ALB has more recent analyst coverage (25 ratings vs 7 for BCPC).
- Company
- Albemarle Corporation
- Balchem Corporation
- Price
- $95.50-2.67%
- $170.60-0.03%
- Market cap
- $11.59B
- $5.44B
- 1M return
- -17.02%
- +2.91%
- 1Y return
- -0.74%
- +13.03%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 1
- Recent ratings
- 25
- 7
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Latest ALB
- Rocket Thrusters on a Road Car Arrive as EV Makers Split Into Winners and Laggards
- Albemarle upgraded by Mizuho
- Barclays initiated coverage on Albemarle with a new price target
- Director Wolff Alejandro Daniel was granted 45 shares, increasing direct ownership by 0.34% to 13,089 units (SEC Form 4)
- Albemarle Corporation to Release Third Quarter 2026 Earnings Results on Wednesday, November 4, 2026
- SEC Form SD filed by Albemarle Corporation
- Chief Commercial Officer Norris Eric was granted 10,867 shares, increasing direct ownership by 20% to 64,310 units (SEC Form 4)
- Chief Operations Officer Mummert Mark Richard was granted 6,086 shares, increasing direct ownership by 35% to 23,601 units (SEC Form 4)
- Chief People Officer Gagarinas Autumn M. was granted 5,217 shares, increasing direct ownership by 97% to 10,610 units (SEC Form 4)
- Chief Accounting Officer Hood Max was granted 1,476 shares (SEC Form 4)
Latest BCPC
- Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026
- New insider Gonzalez Ren Anthony claimed ownership of 7,219 shares (SEC Form 3)
- Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
- SEC Form 10-Q filed by Balchem Corporation
- Balchem Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Balchem Corporation Reports Second Quarter 2026 Financial Results
- Balchem Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026
- Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
- Balchem Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders